Inflammatory bowel disease

Some people with moderate-to-severe Crohn’s who don’t fully respond to one advanced therapy may hear about adding a second drug. This article explains when clinicians might consider that approach, the potential benefits...

This study suggests acne is a common real-world side effect of upadacitinib for IBD and can affect treatment decisions and quality of life, especially for younger patients.

Early “top-down” infliximab plus an immunomodulator was linked to much lower 5-year risk of abdominal surgery, disease progression, and hospitalization versus a step-up approach. This could influence treatment planning...

New clinical results for TREMFYA in perianal fistulizing Crohn's disease and positive data for another J&J IBD drug could signal future treatment options or regulatory milestones that matter to people with Crohn's and...

Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from pressreader.com.

Personal stories like this can offer hope, show real-world coping strategies, and highlight how Crohn’s can affect work, weight, energy, and daily life. It may also raise awareness about delayed diagnosis and the...

IBD affects many parts of life, not just the digestive tract — symptoms, mental health, work and school can all be disrupted. The article highlights support options and a free webinar/guide from a patient advocacy group...

New long-term and real-world data on SKYRIZI and RINVOQ were presented at DDW, which may influence how clinicians, payers, and patients view these options for Crohn's disease and ulcerative colitis.

Based on the title and source metadata, this appears to be a market or business news related to Crohn's disease, Inflammatory bowel disease, and Guselkumab. The original article is from firstwordpharma.com.

Building a care team can help you manage Crohn’s long term — this article explains which clinicians may be involved and what each one does. It also gives practical tips for visits, mental-health support, and nutrition,...

This affects people with IBD because it describes late-stage testing decisions for a combination biologic therapy that targets ulcerative colitis and Crohn’s disease. If pursued, the approach could change future...

Cure8 could only read part of this source from wlrfm.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness.

Based on the title and source metadata, this appears to be a clinical trial phase 3 related to Crohn's disease, Inflammatory bowel disease, and Upadacitinib. The original article is from msn.com.

A book describing a personal recovery from Crohn’s through diet, fitness, and faith may interest people looking for lifestyle approaches or peer experiences. It’s not clinical evidence but could offer practical ideas or...

Cure8 could only read part of this source from ajmc.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease and Research and clinical trials.

Cure8 found this source from hmpgloballearningnetwork.com, but the page could not be read reliably yet. It is tagged for Ulcerative colitis, Crohn's disease, and Inflammatory bowel disease. Open the original article for...

Many people with Crohn’s ask whether specific diets can reduce inflammation rather than only avoiding triggers. This randomized trial reports symptom and stool-marker improvements with a brief, repeated plant-based...

Cure8 found this source from medpagetoday.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Tests and monitoring. Open the original article for the full...

Cure8 found this source from tipranks.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...

Dietary strategies are being studied as active therapies for inducing remission in IBD, not just for symptom control or nutrition. Many patients struggle with malnutrition, and some diets (especially EEN and CDED) have...

Based on the title and source metadata, this appears to be an event or fundraiser related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.

Perianal fistulas are a significant complication of Crohn’s disease that can be hard to treat. A phase 3 trial reported that guselkumab improved combined fistula remission versus placebo, which could represent a new...

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease and Mental health and quality of life. The original article is from msn.com.

Market reports signal where research and new drug investment are going, which can affect future treatment options, drug availability, and pricing. For people living with Crohn’s disease, trends toward more biologics,...

This reports Phase 2b results for a new investigational biologic (JNJ-4804) that targets both IL-23 and TNF and showed higher clinical and endoscopic responses in patients with refractory UC and CD — a group with few...

Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Mirikizumab.

Cure8 could only read part of this source from 1011now.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness.

Based on the title and source metadata, this appears to be a conference abstract related to Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease. The original article is from msn.com.

If you had bowel surgery for Crohn’s disease and develop postoperative anastomotic bleeding, this study suggests endoscopic treatment can stop bleeding in most patients and may avoid another operation. Patients who need...

Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Guselkumab.

Cure8 found this source from streetinsider.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Guselkumab. Open the original article for the full details.

Based on the title and source metadata, this appears to be a case report related to Crohn's disease, Inflammatory bowel disease, and Complications. The original article is from cureus.com.

Surgical technique after ileocolic resection may influence how likely Crohn’s disease is to come back near the anastomosis.

New long-term and real-world data about risankizumab and upadacitinib may influence treatment choices and expectations about symptom relief, steroid-sparing effects, treatment persistence, and hospitalization risk for...

This study looks at upadacitinib in people with Crohn’s disease who did not respond to anti-TNF drugs — a common and challenging clinical situation.

Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Risankizumab.

Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...

Starting college brings new routines, living situations, and social pressures that can affect IBD management. Practical planning around food, medications, stress, and support can help reduce the risk of flares and make...

Mucosal healing is a treatment goal that aims to stop internal intestinal inflammation, not just symptoms. Achieving mucosal healing is linked with fewer hospitalizations, less need for surgery, and lower rates of...

Based on the title and source metadata, this appears to be a regulatory update related to Crohn's disease, Inflammatory bowel disease, and Ustekinumab. The original article is from jnj.com.

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.

This report summarizes recent late-stage trial results, regulatory actions, and new biosimilar launches that could affect treatment options, availability, and drug costs in Crohn’s disease over the coming years.

Market shifts influence availability, cost, and development of new Crohn's disease treatments. Wider use of biosimilars and growth in biologics/small molecules can affect access and treatment choices over time.

Based on the title and source metadata, this appears to be a patient story related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from msn.com.

This study tests a live Faecalibacterium prausnitzii probiotic (EXL01) as a way to prolong steroid-induced remission in Crohn’s disease, a potential new strategy to reduce relapses and steroid exposure.

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease and Diet and lifestyle. The original article is from msn.com.

This work targets a possible root cause (epithelial stress and cell death) rather than only suppressing inflammation — if validated in humans, it could offer new treatment options for people who don’t respond to current...

This study suggests a different treatment target for Crohn’s disease: fixing damaged intestinal lining rather than only suppressing inflammation. If validated in humans, repurposed cancer drugs could speed development of...